UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies

The EMBO journal, 2021-10, Vol.40 (19), p.e107985-n/a

2021

Volltextzugriff (PDF)

Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design

Nature communications, 2024-01, Vol.15 (1), p.411-411, Article 411

2024

Volltextzugriff (PDF)

Crystal Structure of the Archaeal Ammonium Transporter Amt-1 from Archaeoglobus fulgidus

Proceedings of the National Academy of Sciences - PNAS, 2005-10, Vol.102 (42), p.14994-14999

2005

Volltextzugriff (PDF)

N4-hydroxycytidine, the active compound of Molnupiravir, promotes SARS-CoV-2 mutagenesis and escape from a neutralizing nanobody

iScience, 2023-10, Vol.26 (10), p.107786-107786, Article 107786

2023

Volltextzugriff (PDF)

Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication

iScience, 2022-05, Vol.25 (5), p.104293-104293, Article 104293

2022

Volltextzugriff (PDF)

p63 antagonizes Wnt-induced transcription

Cell cycle (Georgetown, Tex.), 2010-02, Vol.9 (3), p.580-587

2010

Volltextzugriff (PDF)

The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis

The Journal of clinical investigation, 2020-11, Vol.130 (11), p.5765-5781

2020

Volltextzugriff (PDF)

MDM2 binds and ubiquitinates PARP1 to enhance DNA replication fork progression

Cell reports (Cambridge), 2022-05, Vol.39 (9), p.110879-110879, Article 110879

2022

Volltextzugriff (PDF)

CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan

Cell cycle (Georgetown, Tex.), 2023-07, Vol.22 (13), p.1563-1582

2023

Volltextzugriff (PDF)

MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53

Molecular cell, 2016-01, Vol.61 (1), p.68-83

2016

Volltextzugriff (PDF)

CDK4 inhibition diminishes p53 activation by MDM2 antagonists

Cell death & disease, 2018-09, Vol.9 (9), p.918-16, Article 918

2018

Volltextzugriff (PDF)

The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models

Virus research, 2021-09, Vol.302, p.198469-198469, Article 198469

2021

Volltextzugriff (PDF)

Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters

Antiviral research, 2024-01, Vol.221, p.105778-105778, Article 105778

2024

Volltextzugriff (PDF)

Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometry

Nucleosides, nucleotides & nucleic acids, 2024-05, p.1-9

2024

Volltextzugriff (PDF)

Expression, purification and crystallization of the ammonium transporter Amt-1 from Archaeoglobus fulgidus

Acta crystallographica. Section F, Structural biology and crystallization communications, 2005-09, Vol.61 (9), p.861-863

2005

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies

Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design

Crystal Structure of the Archaeal Ammonium Transporter Amt-1 from Archaeoglobus fulgidus

N4-hydroxycytidine, the active compound of Molnupiravir, promotes SARS-CoV-2 mutagenesis and escape from a neutralizing nanobody

Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication

p63 antagonizes Wnt-induced transcription

The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis

MDM2 binds and ubiquitinates PARP1 to enhance DNA replication fork progression

CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan

MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53

CDK4 inhibition diminishes p53 activation by MDM2 antagonists

The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models

Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters

Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometry

Expression, purification and crystallization of the ammonium transporter Amt-1 from Archaeoglobus fulgidus

N4-Hydroxycytidine and Inhibitors of Dihydroorotate Dehydrogenase Synergistically Suppress SARS-CoV-2 Replication

Suchergebnisse filtern